Multimodality therapy for malignant pleural mesothelioma.
作者信息
Weder Walter, Opitz Isabelle
机构信息
Division of Thoracic Surgery, University Hospital Zurich, Raemistrasse 100, 8091 Zurich, Switzerland.
出版信息
Ann Cardiothorac Surg. 2012 Nov;1(4):502-7. doi: 10.3978/j.issn.2225-319X.2012.11.12.
Abstract
摘要
相似文献
1
Multimodality therapy for malignant pleural mesothelioma.恶性胸膜间皮瘤的多模态治疗
Ann Cardiothorac Surg. 2012 Nov;1(4):502-7. doi: 10.3978/j.issn.2225-319X.2012.11.12.
2
Aggressive multimodality therapy for malignant pleural mesothelioma.恶性胸膜间皮瘤的积极多模式治疗
Ann Thorac Surg. 1994 Jul;58(1):24-9. doi: 10.1016/0003-4975(94)91066-9.
3
Role of integrated 18-fluorodeoxyglucose position emission tomography-computed tomography in patients surveillance after multimodality therapy of malignant pleural mesothelioma.多模态治疗恶性胸膜间皮瘤后患者监测中整合 18-氟脱氧葡萄糖正电子发射断层扫描-计算机断层扫描的作用。
J Thorac Oncol. 2010 Mar;5(3):385-8. doi: 10.1097/JTO.0b013e3181cbf465.
4
The mTOR Signaling Pathway Is Associated With the Prognosis of Malignant Pleural Mesothelioma After Multimodality Therapy.mTOR 信号通路与多模式治疗后恶性胸膜间皮瘤的预后相关。
Anticancer Res. 2019 Nov;39(11):6241-6247. doi: 10.21873/anticanres.13833.
5
F-FDG PET/CT in the management of patients with malignant pleural mesothelioma being considered for multimodality therapy: experience of a tertiary referral center.F-FDG PET/CT在考虑接受多模态治疗的恶性胸膜间皮瘤患者管理中的应用：一家三级转诊中心的经验
Br J Radiol. 2018 Jun;91(1086):20170814. doi: 10.1259/bjr.20170814. Epub 2018 Mar 29.
6
Multimodality management of malignant pleural mesothelioma.恶性胸膜间皮瘤的多模式管理
Chest. 1998 Jan;113(1 Suppl):61S-65S. doi: 10.1378/chest.113.1_supplement.61s.
7
Surgery for malignant pleural mesothelioma: why, when and what?恶性胸膜间皮瘤的手术治疗：为何、何时以及何种手术？
Lung Cancer. 2014 May;84(2):103-9. doi: 10.1016/j.lungcan.2014.01.021. Epub 2014 Feb 3.
8
Pleural space perfusion with cisplatin in the multimodality treatment of malignant mesothelioma: a feasibility and pharmacokinetic study.顺铂胸腔灌注在恶性间皮瘤多模式治疗中的应用：一项可行性及药代动力学研究
J Thorac Cardiovasc Surg. 1999 Apr;117(4):759-65. doi: 10.1016/S0022-5223(99)70297-7.
9
Computed tomography features of local pleural recurrence in patients with malignant pleural mesothelioma treated with intensity-modulated pleural radiation therapy.恶性胸膜间皮瘤患者行调强胸膜放疗后局部胸膜复发的 CT 特征。
Eur Radiol. 2019 Jul;29(7):3696-3704. doi: 10.1007/s00330-018-5937-6. Epub 2019 Jan 28.
10
The selective epidermal growth factor receptor tyrosine kinase inhibitor PD153035 suppresses expression of prometastasis phenotypes in malignant pleural mesothelioma cells in vitro.选择性表皮生长因子受体酪氨酸激酶抑制剂PD153035在体外抑制恶性胸膜间皮瘤细胞中促转移表型的表达。
J Thorac Cardiovasc Surg. 2005 May;129(5):1010-7. doi: 10.1016/j.jtcvs.2004.10.040.
引用本文的文献
1
Immunotherapy for Treatment of Pleural Mesothelioma: Current and Emerging Therapeutic Strategies.胸膜间皮瘤的免疫治疗：当前和新兴的治疗策略。
Int J Mol Sci. 2024 Oct 9;25(19):10861. doi: 10.3390/ijms251910861.
2
The past, present, and future of targeted therapeutic approaches in patients with diffuse pleural mesotheliomas.弥漫性胸膜间皮瘤患者靶向治疗方法的过去、现在与未来
J Cancer Metastasis Treat. 2023;9. doi: 10.20517/2394-4722.2022.140. Epub 2023 May 30.
3
The Role of Surgery in Pleural Mesothelioma.手术在胸膜间皮瘤中的作用
Cancers (Basel). 2024 Apr 28;16(9):1719. doi: 10.3390/cancers16091719.
4
Pleurectomy decortication is the preferred surgical procedure in pleural mesothelioma.胸膜切除术加去皮质术是胸膜间皮瘤首选的外科手术。
Transl Lung Cancer Res. 2023 Feb 28;12(2):190-192. doi: 10.21037/tlcr-22-906. Epub 2023 Feb 14.
5
Genomic and transcriptomic analysis of a diffuse pleural mesothelioma patient-derived xenograft library.弥漫性胸膜间皮瘤患者来源异种移植文库的基因组和转录组分析。
Genome Med. 2022 Nov 15;14(1):127. doi: 10.1186/s13073-022-01129-4.
6
Multimodality Therapy in Patients With Primary Pericardial Mesothelioma.原发性心包间皮瘤患者的多模态治疗。
J Thorac Oncol. 2022 Dec;17(12):1428-1432. doi: 10.1016/j.jtho.2022.08.017. Epub 2022 Sep 6.
7
The prognostic value of 18F-fluorodeoxyglucose positron emission tomography/ computed tomography parameters in patients with malignant pleural mesothelioma.18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描参数对恶性胸膜间皮瘤患者的预后价值
Turk Gogus Kalp Damar Cerrahisi Derg. 2021 Jan 13;29(1):92-100. doi: 10.5606/tgkdc.dergisi.2021.20432. eCollection 2021 Jan.
8
Stereotactic Body Radiation Therapy (SBRT) as Salvage Therapy for Oligorecurrent Pleural Mesothelioma After Multi-Modality Therapy.立体定向体部放射治疗（SBRT）作为多模式治疗后寡转移复发性胸膜间皮瘤的挽救性治疗方法。
Front Oncol. 2019 Sep 26;9:961. doi: 10.3389/fonc.2019.00961. eCollection 2019.
9
Multimodality treatment of malignant pleural mesothelioma.恶性胸膜间皮瘤的多模态治疗
F1000Res. 2018 Oct 22;7. doi: 10.12688/f1000research.15796.1. eCollection 2018.
10
Chemo-manipulation of tumor blood vessels by a metal-based anticancer complex enhances antitumor therapy.通过基于金属的抗癌配合物对肿瘤血管进行化疗操纵增强抗肿瘤治疗。
Sci Rep. 2018 Jul 6;8(1):10263. doi: 10.1038/s41598-018-28589-2.
本文引用的文献
1
Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma.根治性胸膜切除术和术中光动力疗法治疗恶性胸膜间皮瘤。
Ann Thorac Surg. 2012 May;93(5):1658-65; discussion 1665-7. doi: 10.1016/j.athoracsur.2012.02.009.
2
Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume.胸膜外全肺切除术后上皮性恶性胸膜间皮瘤：基于 CT 肿瘤体积的生存分层。
AJR Am J Roentgenol. 2012 Feb;198(2):359-63. doi: 10.2214/AJR.11.7015.
3
The MARS feasibility trial: conclusions not supported by data.MARS可行性试验：数据不支持的结论。
Lancet Oncol. 2011 Nov;12(12):1093-4; author reply 1094-5. doi: 10.1016/S1470-2045(11)70307-2.
4
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study.胸膜外全肺切除术与非胸膜外全肺切除术治疗恶性胸膜间皮瘤患者的比较：间皮瘤和根治性手术（MARS）随机可行性研究的临床结果。
Lancet Oncol. 2011 Aug;12(8):763-72. doi: 10.1016/S1470-2045(11)70149-8. Epub 2011 Jun 30.
5
Update on malignant pleural mesothelioma.恶性胸膜间皮瘤的最新进展。
Semin Respir Crit Care Med. 2011 Feb;32(1):102-10. doi: 10.1055/s-0031-1272874. Epub 2011 Apr 15.
6
Photodynamic therapy for malignant pleural mesothelioma: the future of treatment?光动力疗法治疗恶性胸膜间皮瘤：治疗的未来？
Expert Rev Respir Med. 2011 Feb;5(1):49-63. doi: 10.1586/ers.11.1.
7
Optimized intrapleural cisplatin chemotherapy with a fibrin carrier after extrapleural pneumonectomy: a preclinical study.胸腔外肺切除术后纤维蛋白载体优化顺铂腔内化疗：临床前研究。
J Thorac Cardiovasc Surg. 2011 Jan;141(1):65-71. doi: 10.1016/j.jtcvs.2010.09.032.
8
A systematic review of extrapleural pneumonectomy for malignant pleural mesothelioma.胸腔外全肺切除术治疗恶性胸膜间皮瘤的系统评价。
J Thorac Oncol. 2010 Oct;5(10):1692-703. doi: 10.1097/JTO.0b013e3181ed0489.
9
Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial.恶性胸膜间皮瘤的三联疗法：来自 EORTC 二期多中心试验的结果。
Eur Respir J. 2010 Dec;36(6):1362-9. doi: 10.1183/09031936.00039510. Epub 2010 Jun 4.
10
Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor in mesothelioma.可溶性间皮素和巨核细胞促进因子在间皮瘤中的诊断性能。
Am J Respir Crit Care Med. 2010 Mar 15;181(6):620-5. doi: 10.1164/rccm.200907-1020OC. Epub 2010 Jan 14.
Zotero 插件